Table 2 Summary of clinical and pathological details for ciliary and choroidal melanomas with and without the BRAF mutation
From: The T1799A point mutation is present in posterior uveal melanoma
|  | Average age (range) | Sex (F : M) | Average largest tumour dimension (range, mm) | Cell type (S:E:M) | Vascular loops (Y:N) | Metastases Y:N:not known | Follow-up range (months) |
|---|---|---|---|---|---|---|---|
Ciliary Body | |||||||
 BRAF mutation | 33 (16–48) | 9F:7M | 15.5 (10–20) | 3:0:1 | 3:1 | 0:3:1 | N/A |
 BRAF wild type | 59 (30–80) | 2F:2M | 12.7 (5–22) | 7:0:9 | 7:9 | 1:6:9 | N/A |
Choroid | |||||||
 BRAF mutation | 51 (42–69) | 6F:5M | 14.5 (10–18) | 5:1:5 | 9:2 | 8:3:0 | 4–337 |
 BRAF wild type | 57 (19–75) | 11F:8M | 14.7 (8–23) | 11:0:8 | 12:7 | 8:11:0 | 30–344 |
